Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥3.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥90m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥120m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥70m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥305m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥69m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥69m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.4bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.8bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥664mat 2023-09-30Cons.Liabilities
Total liabilities¥781mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥141m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥541m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥483m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥485m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.132023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.622022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.822022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio90.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.0%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m
Reconciling Itemsreconcilingsegment ordinary income2022-04-01 → 2022-09-30−¥286m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥674m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥222m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥903m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2022-04-01 → 2022-09-30¥134m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.6bn
—segment totalsegment ordinary income2022-04-01 → 2022-09-30¥356m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 486
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember1380300
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.0162
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember1016950
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0119
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1000000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0117
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember823600
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0096
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember620000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0072
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember500000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0058
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember384000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0045
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember379000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0044
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember345700
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0040
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember331000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0038
Number of shares heldCurrentQuarterInstant6780550
Shareholding ratioCurrentQuarterInstant0.0796
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember53700
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember85059500
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember850595
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember27991
Number of shares issued shares voting rightsCurrentQuarterInstant85141191
Number of voting rights issued shares voting rightsCurrentQuarterInstant850595
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member53700
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member53700
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0006
Number of shares held in own name treasury shares etcCurrentQuarterInstant53700
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant53700
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0006
Cash and depositsPrior1YearInstant1914569000JPY
Cash and depositsCurrentQuarterInstant2085379000JPY
Accounts receivable tradePrior1YearInstant445775000JPY
Accounts receivable tradeCurrentQuarterInstant338240000JPY
Short term investment securitiesPrior1YearInstant4464845000JPY
Short term investment securitiesCurrentQuarterInstant2987055000JPY
Merchandise and finished goodsPrior1YearInstant58259000JPY
Merchandise and finished goodsCurrentQuarterInstant52588000JPY
Work in processPrior1YearInstant41207000JPY
Work in processCurrentQuarterInstant41737000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass